in the Journal of Endocrinology and Metabolism reported AOD 9604 to be well-tolerated across tested doses, with no observed alterations in IGF-1 levels, blood glucose, or insulin sensitivity
The therapy is typically delivered through injections and overseen by healthcare professionals
AOD-9604 is a modified fragment of human growth hormone (amino acids 176 to 191) that directly stimulates fat cell breakdown (lipolysis) while blocking new fat formation (lipogenesis)
Most research up to this point has been on animals, with limited human research, but there are mountains of anecdotal evidence that helps support the purported anti-aging effects
Reduce inflammation in the brain
[5] The primary contraindication for hydroxocobalamin injection is a known hypersensitivity to hydroxocobalamin, cobalt, or any component of the formulation